-
effectivehealthcare.ahrq.gov/sites/default/files/s123.pdf
October 01, 2007 - ORIGINAL ARTICLE
Heterogeneity and the Interpretation of Treatment Effect
Estimates From Risk Adjustment and Instrumental
Variable Methods
John M. Brooks, PhD,* and Elizabeth A. Chrischilles, PhD†
Objectives: To contrast the interpretations of treatment effect esti-
mates using risk adjustment and instrumental vari…
-
effectivehealthcare.ahrq.gov/sites/default/files/s103.pdf
October 01, 2007 - ORIGINAL ARTICLE
Using Inverse Probability-Weighted Estimators in
Comparative Effectiveness Analyses With Observational
Databases
Lesley H. Curtis, PhD,*† Bradley G. Hammill, MS,* Eric L. Eisenstein, DBA,*†
Judith M. Kramer, MD, MS,* and Kevin J. Anstrom, PhD*‡
Abstract: Inverse probability-weighted estimation is a…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/opioid-use-disorder_research-protocol.pdf
February 24, 2016 - medication-assisted-treatment-protocol-160224
Source: www.effectivehealthcare.ahrq.gov
Published online: February 24, 2016
Evidence-based Practice Center Technical Brief Protocol
Project Title: Medication-Assisted Treatment Models of Care for
Opioid Use Disorder
I. Background and Objectives for t…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/autism_research-protocol.pdf
December 09, 2009 - Evidence-based Practice Center Systematic Review Protocol
Source: www.effectivehealthcare.ahrq.gov
Published Online: December 7, 2009
1
Evidence-based Practice Center Systematic Review Protocol
Project Title: Therapies for Children with Autism
Spectrum Disorders
I. Backgrou…
-
effectivehealthcare.ahrq.gov/sites/default/files/therapies-for-autism-spectrum-disorder-2-9-2010.pdf
January 01, 2010 - Evidence-based Practice Center Systematic Review Protocol
Source: www.effectivehealthcare.ahrq.gov
Published Online: December 7, 2009
1
Evidence-based Practice Center Systematic Review Protocol
Project Title: Therapies for Children with Autism
Spectrum Disorders
I. Backgrou…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-opioid-chronic-pain-surveillance-report-3.xlsx
September 30, 2015 - Appendix Table D-1. RCTs
Table D-1. Randomized controlled trials
Author, Year Study Design
Duration Setting
Country Eligibility Criteria Interventions Sample Characteristics Screened
Eligible
Randomized
Analyzed Results Adverse Events and Withdrawals Due to Adverse Events Sponsor Quality
Hruschak, 2021 RCT
Duration:…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/chronic-pain-opioid-treatment_executive.pdf
September 19, 2014 - the
small number of studies available for each Key Question;
variability in study designs, patient samples … clinic settings.50-60 An important reason for the
variability in estimates is differences in patient samples
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/mrsa-screening_research.pdf
June 01, 2013 - To identify the population of colonized individuals, microbiological samples are obtained
from at-risk … To identify the population of colonized individuals, microbiological samples are obtained
from at-risk
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/pharma-nonpharma-ptsd-2022-update-executive-summ.pdf
January 01, 2022 - Executive Summary_Systematic Review_Pharmacologic and Nonpharmacologic Treatments for Posttraumatic Stress Disorder: 2022 Update of the PTSD-Repository Evidence Base
Systematic Review
Pharmacologic and Nonpharmacologic Treatments
for Posttraumatic Stress Disorder: 2022 Update of
the PTSD-Repository Evidenc…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-276-ocd-appendix-g.xlsx
January 01, 2022 - Design
Appendix G. Key Question 1 Full Extractions
Table G-1. Key Question 1: Design and baselines
PMID First Author Publication Year Extractor Study Directionality Study Years (e.g. 1990-1997) Country Age, Mean (SD) or Median (IQR) Age Range (e.g., 7-17) Male, N (%) Race: White, N (%) Race: Black/African American, …
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/diabetes-behavior-programs_disposition-comments.pdf
September 28, 2015 - Thinning is needed to get relatively independent
posterior samples. … Since the minority
samples usually had poorer glycemic control, it is not
clear if the interventions
-
effectivehealthcare.ahrq.gov/system/files/docs/topic-brief-antenatal-care.pdf
April 01, 2021 - Topic Brief: Antenatal Care
1
Topic Brief: Antenatal Care
Date: 6/30/2020
Nomination Number: 0902
Purpose: This document summarizes the information addressing a nomination submitted on
April 7, 2020 through the Effective Health Care Website. This information was used to inform
the Evidence-based Pract…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/gout_executive-2016.pdf
January 01, 2016 - by patient differences, differences in skill levels
of the practitioners drawing or analyzing the samples … systematic
review of the accuracy of methods for detecting MSU in
synovial fluid concluded that storage of samples … residents in identifying
MSU and calcium pyrophosphate crystals found that
fewer than half identified all samples
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/indirect-comparisons_research-2013.pdf
January 01, 2013 - number of studies investigating the therapy, and the
thickness of each edge denotes the total number of samples … For the OA data analysis, WinBUGS is used to generate two parallel chains of 50,000
MCMC samples after … In each case, we obtain
20,000 samples, after a 20,000 sample burn-in, and collect medians of parameters … number of studies investigating the therapy, and the thickness of each edge implies the total number of samples
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/transparency-neuropathy_research.pdf
March 01, 2018 - Supplemental Project To Assess the Transparency of Reporting Requirements for Studies Evaluating the Effectiveness of Treatment Options for Symptoms of Diabetic Peripheral Neuropathy
Methods Research Report
Supplemental Project To Assess the Transparency of
Reporting Requirements for Studies E…
-
effectivehealthcare.ahrq.gov/sites/default/files/sensitivity-analysis-chapter-11.pptx
January 01, 2013 - Slide 1
Sensitivity Analysis for Observational Comparative Effectiveness Research
Prepared for:
Agency for Healthcare Research and Quality (AHRQ)
www.ahrq.gov
Sensitivity Analysis for Observational Comparative Effectiveness Research
This slide set is based on a user guide titled Developing a Protocol for Observati…
-
effectivehealthcare.ahrq.gov/sites/default/files/considerations-for-statistical-chapter-10.pptx
January 01, 2013 - Covariate Selection for Observational Comparative Effectiveness Research
Considerations for Statistical Analysis in Observational Comparative Effectiveness Research
Prepared for:
Agency for Healthcare Research and Quality (AHRQ)
www.ahrq.gov
Considerations for Statistical Analysis in Observational Comparative Effe…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/suda-final-protocol.pdf
October 02, 2018 - adolescent
substance use treatment trials, many of which have employed more rigorous designs, larger
samples
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/chronic-kidney-disease-anemia_research.pdf
January 01, 2013 - Resource Use, Size, and Duration
Cohort studies often require large samples, so it may be necessary … Resource Use, Size, and Duration
Cohort studies often require larger samples, so it may be necessary
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/transparency-omega-3_research-protocol.pdf
September 02, 2016 - Transparency of Reporting Requirements: Omega-3 Fatty Acids and Cardiovascular Disease
Source: www.effectivehealthcare.ahrq.gov
Published online: September 2, 2016
Evidence-based Practice Center Methodology Repor t Protocol
Project Title: Transparency of Repor ting Requirements
Repor t Topic: Omega-3 Fa…